Pathway and single gene analyses of inhibited Caco-2 differentiation by ascorbate-stabilized quercetin suggest enhancement of cellular processes associated with development of colon cancer

Molecular Nutrition and Food Research

Volumn 51, Issue 8, 2007, Pages 1031-1045

  Dihal, Ashwin A ^a,b   Tiiburgs, Chantal ^a   Van Erk, Marjan J ^a   Rietjens, Ivonne M C M ^b   Woutersen, Ruud A ^a   Stlerum, Rob H ^a  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Caco 2; Colorectal cancer; Differentiation; Microarray; Quercetin

Indexed keywords

ASCORBIC ACID; QUERCETIN;

ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL STRAIN CACO 2; COLON TUMOR; COMPARATIVE STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG STABILITY; GENE EXPRESSION; GENETICS; HUMAN; PATHOLOGY;

ASCORBIC ACID; CACO-2 CELLS; CELL DIFFERENTIATION; CELL DIVISION; COLONIC NEOPLASMS; DRUG STABILITY; GENE EXPRESSION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUERCETIN;

EID: 34548090545     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200600261     Document Type: Article

References (56)

1. Manach, C., Sealbert, A., Morand, C., Remesy, C., Jimenez, L., Polyphenols: Food sources and bioavailability, Am. J. Clin. Nutr. 2004, 79, 727-747.
2. Day, A. J., DuPont, M. S., Ridley, S., Rhodes, M., et al., Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity, FEBS Lett. 1998, 436, 71-75.
3. Kim, D. H., Jung, E. A., Sohng, I. S., Han, J. A., et al., Intestinal bacterial metabolism of flavonoids and its relation to some biological activities, Arch. Pharm. Res. 1998, 21, 17-23.
4. Hollman, P. C., van Trijp, J. M., Buysman, M. N., van der Gaag, M. S., et al., Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man, FEBS Lett. 1997, 418, 152-156.
5. Mariadason, J. M., Arango, D., Corner, G. A., Aranes, M. J., et al., A gene expression profile that defines colon cell maturation in vitro, Cancer Res. 2002, 62, 4791-4804.
6. Stierum, R., Gaspari, M., Dommels, Y., Ouatas, T., et al., Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2, Biochim. Biophys. Acta 2003, 1650, 13-91.
7. Fodde, R., The APC gene in colorectal cancer, Eur. J. Cancer 2002, 38, 867-871.
8. Fleet, J. C., Wang, L., Vitek, O., Craig, B. A., Edenberg, H. J., Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation, Physiol. Genomics 2003, 13, 57-68.
9. Molmenti, E. P., Ziambaras, T., Perlmutter, D. H., Evidence for an acute phase response in human intestinal epithelial cells, J. Biol. Chem. 1993, 268, 14116-14124.
10. Van Erk, M. J., Roepman, P., Van Der Lende, T. R., Stierum, R. H. et al., Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro, Eur. J. Nutr. 2005, 44, 143-156.
11. Kuo, S. M., Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells, Cancer Lett. 1996, 110, 41-48.
12. Dihal, A. A., de Boer, V. C. J., van der Woude, H., Tilburgs, C. et al., Quercetin, but not its glycosylated conjugate rutin, inhibits azoxymethane-induced colorectal carcinogenesis in F344 rats, J. Nutr. 2006, 136, 2862-2867.
13. Deschner, E. E., Ruperto, J., Wong, G., Newmark, H. L., Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia, Carcinogenesis 1991, 12, 1193-1196.
14. Pereira, M. A., Grubbs, C. J., Barnes, L. H., Li, H., et al., Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7, 12-dimethylbenz[a]anthracene-induced mammary cancer in rats, Carcinogenesis 1996, 17, 1305-1311.
15. Dihal, A. A., Woutersen, R. A., van Ommen, B., Rietjens, I. M. C. M, Stierum, R. H., Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2, Cancer Lett. 2006, 238, 248-259.
16. Engle, M. J., Grove, M. L., Becich, M. J., Mahmood, A., Alpers, D. H., Appearance of surfactant-like particles in apical medium of Caco-2 cells may occur via tight junctions, Am. J.Physiol. 1995, 268, C1401-C1413.
17. Tietze, C. C., Becich, M. J., Engle, M., Stenson, W F., et al., Caco-2 cell transfection by rat intestinal alkaline phosphatase cDNA increases surfactant-like particles, Am. J. Physiol. 1992, 263, G756-G766.
18. Storey, J. D., Tibshirani, R., Statistical significance for genomewide studies, Proc. Natl Acad. Sci. USA 2003, 100, 9440-9445.
19. Ohta, T., Takahashi, M., Ochiai, A., Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers, Cancer Lett. 2006, 239, 246-253.
20. Adachi, Y., Yamamoto, H., Itoh, F., Hinoda, Y., et al., Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers, Gut 1999, 45, 252-258.
21. Bustin, S. A., Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays, J. Mol. Endocrinol. 2000, 25, 169-193.
22. Howell, S., Kenny, A. J., Turner, A. J., A survey of membrane peptidases in two human colonic cell lines, Caco-2 and HT-29, Biochem. J 1992, 284, 595-601.
23. Faller, G., Dimmler, A., Rau, T., Spaderna, S., et al., Evidence for acid-induced loss of Cdx2 expression in duodenal gastric metaplasia, J. Pathol. 2004, 203, 904-908.
24. Hursting, S. D., Slaga, T. J., Fischer, S. M., DiGiovanni, J., Phang, J. M., Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice, J. Natl. Cancer Inst. 1999, 91, 215-225.
25. Barrier, A., Boelle, P. Y., Lemoine, A., Tse, C., et al., Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients, Dis. Colon Rectum 2005, 48, 2238-2248.
26. Hertog, M. G., Feskens, E. J., Hollman, P. C., Katan, M. B., Kromhout, D., Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study, Lancet 1993, 342, 1007-1011.
27. Wang, Y., Jatkoe, T., Zhang, Y., Mutch, M. G., et al., Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer, J. Clin. Oncol. 2004, 22, 1564-1571.
28. Brandeis, M., Rosewell, I., Carrington, M., Crompton, T., et al., Cyclin B2-null mice develop normally and are fertile whereas cyclin Bl-null mice die in utero, Proc. Natl. Acad. Sci. USA 1998, 95, 4344-4349.
29. Adams, R. R., Eckley, D. M., Vagnarelli, P., Wheatley, S. P., et al., Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells, Chromosoma 2001, 110, 65-74.
30. Heaney, A. P., Singson, R., McCabe, C. J., Nelson, V., et al., Expression of pituitary-tumour transforming gene in colorectal tumours, Lancet 2000, 355, 716-719.
31. De Angelis, P. M., Fjell, B., Kravik, K. L., Haug, T., et al., Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil, Int. J. Oncol. 2004, 24, 1279-1288.
32. Van der Logt, E. M., Roelofs, H. M., Nagengast, F. M., Peters, W. H., Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens, Carcinogenesis 2003, 24, 1651-1656.
33. Wenzel, U., Nickel, A., Kuntz, S., Daniel, H., Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions, Carcinogenesis 2004, 25, 703-712.
34. Connelly, A. E., Satia-Abouta, J., Martin, C. F., Keku, T. O., et al., Vitamin C intake and apoptosis in normal rectal epithelium, Cancer Epidemiol. Biomarkers Prev. 2003, 12, 559-565.
35. Dommels, Y. E., Haring, M. M., Keestra, N. G., Alink, G. M., et al., The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines, Carcinogenesis 2003, 24, 385-392.
36. Schlichter, S., Amasheh, M. M., Amasheh, S., Fromm, M., Schulzke, J. D., The flavonoid quercetin improves the epithelial barrier function in Caco-2 cells, J Physiol. Biochem. 2005, 61, 576.
37. Lee-Hilz, Y. Y., Boerboom, A. M., Westphal, A. H., Van Berkel, W. J. H., et al., Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression, Chem. Res. Toxicol. 2006, 19, 1499-1505.
38. Dube, N., Delvin, E., Yotov, W., Garofalo, C., et al., Modulation of intestinal and liver fatty acid-binding proteins in Caco-2 cells by lipids, hormones and cytokines, J. Cell Biochem. 2001, 81, 613-620.
39. Agrawal, D., Chen, T., Irby, R., Quackenbush, J., et al., Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling, J. Natl. Cancer Inst. 2002, 94, 513-521.
40. Katayama, H., Ota, T., Jisaki, F., Ueda, Y., et al., Mitotic kinase expression and colorectal cancer progression, J. Natl. Cancer Inst. 1999, 91, 1160-1162.
41. Bassal, S., Nomura, N., Venter, D., Brand, K., et al., Characterization of a novel human cell-cycle-regulated homologue of Drosophila dlg1, Genomics 2001, 77, 5-7.
42. Birkenkamp-Demtroder, K., Christensen, L. L., Olesen, S. H., Frederiksen, C. M., et al., Gene expression in colorectal cancer, Cancer Res. 2002, 62, 4352-4363.
43. Chiu, S. T., Hsieh, F. J., Chen, S. W., Chen, C. L., et al., Clinicopathologic correlation of up-regulated genes identified using cDNA microarray and real-time reverse transcription-PCR in human colorectal cancer, Cancer Epidemiol. Biomarkers Prev. 2005, 14, 437-443.
44. Banerjea, A., Ahmed, S., Hands, R. E., Huang, F., et al., Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity, Mol. Cancer 2004, 3, 21.
45. Hittelet, A., Legendre, H., Nagy, N., Bronckart, Y., et al., Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration, Int. J. Cancer 2003, 103, 370-379.
46. Xiong, B., Yuan, H. Y., Hu, M. B., Zhang, F., et al., Transforming growth factor-beta1 in invasion and metastasis in colorectal cancer, World J. Gastroenterol. 2002, 8, 674-678.
47. Notterman, D. A., Alon, U., Sierk, A. J., Levine, A. J., Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays, Cancer Res. 2001, 61, 3124-3130.
48. Graudens, E., Boulanger, V., Mollard, C., Mariage-Samson, R. et al., Deciphering cellular states of innate tumor drug responses, Genome Biol. 2006, 7, R19.
49. Dong, X. Y., Yang, X. A., Wang, Y. D., Chen, W. F., Zinc-finger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients, Br. J. Cancer 2004, 91, 1566-1570.
50. Lottaz, D., Maurer, C. A., Hahn, D., Buchler, M. W., Sterchi, E. E., Nonpolarized secretion of human meprin alpha in colorectal cancer generates an increased proteolytic potential in the stroma, Cancer Res. 1999, 59, 1127-1133.
51. McKay, J. A., Murray, G. I., Weaver, R. J., Ewen, S. W., et al., Xenobiotic metabolising enzyme expression in colonic neoplasia, Gut 1993, 34, 1234-1239.
52. De Waziers, I., Cugnenc, P. H., Berger, A., Leroux, J. P., Beaune, P. H., Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples, Carcinogenesis 1991, 12, 905-909.
53. Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., et al., Multiclass cancer diagnosis using tumor gene expression signatures, Proc. Natl. Acad. Sci. USA 2001, 98, 15149-15154.
54. Otsuka, M., Kato, M., Yoshikawa, T., Chen, H., et al., Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis, Biochem. Biophys. Res. Commun. 2001, 289, 876-881.
55. Lechner, S., Muller-Ladner, U., Neumann, E., Dietmaier, W., et al., Use of simplified transcriptors for the analysis of gene expression profiles in laser-microdissected cell populations, Lab Invest. 2001, 81, 1233-1242.
56. Holcombe, R. F., Marsh, J. L., Waterman, M. L., Lin, F., et al., Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma, Mol. Pathol. 2002, 55, 220-226.